| Salam Syed, MD | |
|
210 N Main St Ste 103, Deforest, WI 53532-1163 | |
| (414) 873-9800 | |
| Not Available |
| Full Name | Salam Syed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 210 N Main St Ste 103, Deforest, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669666731 | NPI | - | NPPES |
| 1669666731 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 53833 (Wisconsin) | Secondary |
| 207R00000X | Internal Medicine | 53833 (Wisconsin) | Primary |
| Entity Name | Urgent Care Physcians, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255744025 PECOS PAC ID: 0648495812 Enrollment ID: O20140701001730 |
News Archive
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Online disease state discussions among patients, physicians, caregivers and other key customer groups is flourishing across both established and emerging online channels. Recognizing the potential value of these online discussions, savvy healthcare companies have launched innovative Social Media Listening programs to capture critical market insights.
Ben W. Strowbridge, Ph.D, associate professor of Neuroscience and Physiology/Biophysics, and Yuan Gao, a Ph.D. student in the neurosciences program at Case Western Reserve University School of Medicine, are the first to discover a form of synaptic memory in the olfactory bulb, the part of the brain that processes the sense of smell.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
› Verified 4 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191118000551 |
News Archive
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Online disease state discussions among patients, physicians, caregivers and other key customer groups is flourishing across both established and emerging online channels. Recognizing the potential value of these online discussions, savvy healthcare companies have launched innovative Social Media Listening programs to capture critical market insights.
Ben W. Strowbridge, Ph.D, associate professor of Neuroscience and Physiology/Biophysics, and Yuan Gao, a Ph.D. student in the neurosciences program at Case Western Reserve University School of Medicine, are the first to discover a form of synaptic memory in the olfactory bulb, the part of the brain that processes the sense of smell.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
› Verified 4 days ago
| Entity Name | Sober Living In Madison Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013633882 PECOS PAC ID: 2264898535 Enrollment ID: O20231020000488 |
News Archive
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Online disease state discussions among patients, physicians, caregivers and other key customer groups is flourishing across both established and emerging online channels. Recognizing the potential value of these online discussions, savvy healthcare companies have launched innovative Social Media Listening programs to capture critical market insights.
Ben W. Strowbridge, Ph.D, associate professor of Neuroscience and Physiology/Biophysics, and Yuan Gao, a Ph.D. student in the neurosciences program at Case Western Reserve University School of Medicine, are the first to discover a form of synaptic memory in the olfactory bulb, the part of the brain that processes the sense of smell.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Salam Syed, MD 210 N Main St, Ste 102, Deforest, WI 53532-1163 Ph: (414) 873-9800 | Salam Syed, MD 210 N Main St Ste 103, Deforest, WI 53532-1163 Ph: (414) 873-9800 |
News Archive
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Online disease state discussions among patients, physicians, caregivers and other key customer groups is flourishing across both established and emerging online channels. Recognizing the potential value of these online discussions, savvy healthcare companies have launched innovative Social Media Listening programs to capture critical market insights.
Ben W. Strowbridge, Ph.D, associate professor of Neuroscience and Physiology/Biophysics, and Yuan Gao, a Ph.D. student in the neurosciences program at Case Western Reserve University School of Medicine, are the first to discover a form of synaptic memory in the olfactory bulb, the part of the brain that processes the sense of smell.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
› Verified 4 days ago